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Quantitative structure–activity relation-
ships (QSARs) have been extensively
applied in a broad range of scientiﬁc areas,
including chemistry, biology and toxicol-
ogy (Hansch et al. 1995a, 1995b). QSAR
is now an inexorably imbedded tool in
drug development, from lead discovery to
lead optimization (Hopfinger and
Tokarski 1997; Kubinyi et al. 1998).
There is increasing use of QSAR early in
the drug discovery process as a screening
and enrichment tool to eliminate from fur-
ther development those chemicals lacking
drug-like properties (Lipinski et al. 1997)
or those chemicals predicted to elicit a
toxic response. The availability of powerful
new algorithms and scientists trained in
their usage suggests the eventual common
use of QSAR beyond the pharmaceutical
industry to human and environmental reg-
ulatory authorities (Benigni and Richard
1998; Bradbury 1994; Hansch et al.
1995a, 1995b; Russom et al. 1995;
Schultz and Seward 2000; Tong et al.
2002, 2003a). 
Any QSAR model produces some
degree of error. This is partially due to the
inherent limitation in predicting a biologi-
cal activity based solely on the chemical
structure. One can argue from the princi-
ples of chemistry that molecular structure
of a chemical is the key to understanding
its physicochemical properties and ulti-
mately its biological activity and the inﬂu-
ence on organisms (Johnson and Maggiora
1990). However, biological activity of a
chemical is an induced response that is
inﬂuenced by numerous factors dictated by
the levels of biological complexity of the
system under investigation. The relation-
ship between structure and activity is thus
more implicit and thereby requires a more
thorough investigation and rigorous valida-
tion (Tong et al., 2004). 
Application of QSARs in regulation has
proven to be cost effective for prioritizing
untested chemicals for more extensive and
costly experimental evaluation. However,
for QSARs to be accepted by the regulatory
communities, their limitation for use needs
to be identiﬁed. This is important because
a QSAR model’s ability to predict
unknown chemicals depends largely on the
nature of the training set and the algorithm
used to establish the structure–activity rela-
tionship (Eriksson et al. 2003). A model’s
predictive accuracy and conﬁdence for dif-
ferent unknown chemicals varies according
to how well the training set represents the
unknown chemicals and how robust the
model is in extrapolating beyond the chem-
istry space deﬁned by the training set (i.e.,
training domain). Therefore, assessing a
model’s “prediction conﬁdence,” deﬁned as
the certainty for a prediction, and “domain
extrapolation,” defined as the prediction
accuracy outside the training domain, is a
vital step toward defining the application
domain of a model for the regulatory
acceptance of QSARs. 
A large number of environmental
chemicals known as endocrine-disrupting
chemicals (EDCs) are suspected of disrupt-
ing endocrine functions by mimicking or
antagonizing natural hormones in experi-
mental animals, wildlife, and humans
(Hileman 1997). EDCs may exert adverse
effects through a variety of mechanisms,
including estrogen receptor (ER)–mediated
mechanisms of toxicity (Fang et al. 2003b).
Accordingly, the U.S. Congress in 1996
mandated that the U.S. Environmental
Protection Agency (EPA) develop a strat-
egy for screening and testing a large num-
ber of chemicals found in drinking water
(Safe Drinking Water Act 1996), and food
additives (Food Quality Protection Act
1996) for their endocrine disruption
potential. Consequently, more than 58,000
environmental and industrial chemicals
have been identiﬁed as candidates for possi-
ble experimental testing. QSARs could be
used as an inexpensive prescreening tool to
prioritize the chemicals for further testing
(Tong et al. 2002).
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Quantitative structure–activity relationship (QSAR) methods have been widely applied in drug
discovery, lead optimization, toxicity prediction, and regulatory decisions. Despite major
advances in algorithms and software, QSAR models have inherent limitations associated with a
size and chemical-structure diversity of the training set, experimental error, and many characteris-
tics of structure representation and correlation algorithms. Whereas excellent ﬁt to the training
data may be readily attainable, often models fail to predict accurately chemicals that are outside
their domain of applicability. A QSAR’s utility and, in the case of regulatory decisions, justiﬁca-
tion for usage increasingly depend on the ability to quantify a model’s potential for predicting
unknown chemicals with some known degree of certainty. It is never possible to predict an
unknown chemical with absolute certainty. Here we report on two QSAR models based on differ-
ent data sets for classiﬁcation of chemicals according to their ability to bind to the estrogen recep-
tor. The models were developed by using a novel QSAR method, Decision Forest, which
combines the results of multiple heterogeneous but comparable Decision Tree models to produce
a consensus prediction. We used an extensive cross-validation process to define an applicability
domain for model predictions based on two quantitative measures: prediction confidence and
domain extrapolation. Together, these measures quantify the accuracy of each prediction within
and outside of the training domain. Despite being based on large and diverse training sets, both
QSAR models had poor accuracy for chemicals within the domain of low confidence, whereas
good accuracy was obtained for those within the domain of high conﬁdence. For prediction in the
high conﬁdence domain, accuracy was inversely proportional to the degree of domain extrapola-
tion. The model with a larger training set of 1,092, compared with 232 for the other, was more
accurate in predicting chemicals at larger domain extrapolation, and could be particularly useful
for rapidly prioritizing potential endocrine disruptors from large chemical universe. Key words:
applicability domain, Decision Forest, domain extrapolation, EDCs, endocrine-disrupting chemi-
cals, estrogen receptor binding, QSAR, prediction confidence, regulatory application. Environ
Health Perspect 112:1249–1254 (2004). doi:10.1289/txg.7125 available via http://dx.doi.org/
[Online 16 July 2004]In this article, we applied a novel
consensus QSAR method, called Decision
Forest (DF) (Tong et al. 2003b), to classify
chemicals into active and inactive cate-
gories of ER binding as a priority-setting
tool for EDCs. We assessed the applicabil-
ity domain of the DF models through
characterizing the prediction confidence
and domain extrapolation for predicting
unknown chemicals. 
Material and Methods
Estrogen Receptor Data Sets
and Structural Descriptors 
Two data sets were used, and the ER
binding activity for both data sets was
obtained from the competitive ER binding
assay (Blair et al. 2000; Branham et al.
2002). The ﬁrst data set, designated ER232,
contained 232 chemicals, 131 active, and
101 inactive that were tested in our lab
(Fang et al. 2003a). This data set has been
extensively used by others and us to develop
SAR/QSAR models for predicting ER bind-
ing activity (Hong et al. 2002; Shi et al.
2001, 2002; Tong et al. 2002, 2003c). The
second data set, designated ER1092, is an
aggregation of data from the literature con-
taining 1,092 chemicals, of which 350
are active and 736 are inactive. Inactive
means that no activity was detectable in the
assay. Both data sets span a wide range of
structural diversity and activity. 
Because a previous study indicated no
signiﬁcant difference in results between two-
dimensional (2D) descriptors and 3D
descriptors in DF (Tong et al. 2003b), only
2D descriptors were used in this study, and
these were computed using Molconn-Z, ver-
sion 4.07 (http://www.eslc.vabiotech.com/
molconn/). After removing descriptors that
were constant across all chemicals in a data
set, more than 270 descriptors remained and
were used in model development. 
The structural diversity of both data
sets was compared in the chemistry space
defined by the 2D descriptors on the first
three principle components plot (Figure 1).
Not surprisingly, ER1092 was found to
span much greater structural diversity than
ER232.
Decision Forest
DF is a consensus modeling technique
(Tong et al. 2003b) that combines multiple
Decision Tree models (hereafter called trees)
in a manner that results in more accurate
predictions. Because combining several
identical trees produces no gain, the ratio-
nale behind DF is use of individual trees
that are different (i.e., heterogeneous) yet
comparable in their prediction accuracy to
represent the association of structure and
biological activity. The heterogeneity
requirement assures that each tree uniquely
contributes to the combined prediction,
whereas the quality comparability require-
ment assures that each tree contributes
equally to the combined prediction. Because
a certain degree of noise is always present in
biological data, optimizing a tree inherently
risks overfitting the noise. DF attempts to
minimize overﬁtting by maximizing the dif-
ference among individual trees to cancel
some random noise through combining the
trees. The maximum difference was
achieved by constructing each individual
tree using a distinct set of descriptors. 
Details of the DF algorithm have been
reported by Tong et al. (2003b). Briefly,
developing a DF model (called forest here-
after) comprises four steps: a) construct
and prune a tree; b) develop the next tree
based on only the descriptors that have not
been used in the previous tree(s); c) repeat
steps 1 and 2 until no more trees can be
developed; d) classify (i.e., predict) a chem-
ical based on the results of all trees.
Each tree in a forest is developed using a
variant of the Classiﬁcation and Regression
Tree (CART) method (Breiman et al. 1995)
that has two steps: a) tree construction and
b) tree pruning. During tree construction,
the algorithm identiﬁes the descriptors that
best divide the chemicals in the parent node
into two child nodes. The split maximizes
the homogeneity of the activity population
in each child node (e.g., one node predomi-
nately contains active chemicals, whereas the
other predominately contains inactive chem-
icals). Then, the child nodes become parent
nodes for further splits and splitting contin-
ues until chemicals in each node are either
in one classification category or cannot be
split further to improve the quality of the
tree. To avoid overﬁtting the training data,
the tree is then cut down to a desired size
using tree cost-complexity pruning (Clark
and Pregibon 1997). At the end, the termi-
nal node of each tree generally is populated
by different ratios of active versus inactive
chemicals. 
In each tree, the probability (0–1) for
an “unknown” chemical to be active is
taken to be the percentage of active chemi-
cals in the terminal node to which the
chemical belongs. The mean probability
value for a chemical in all trees in the forest
is calculated to assign the classification of
the chemical. Chemicals that have a mean
probability > 0.5 are designated active,
whereas those that have a mean probability
< 0.5 are designated inactive.
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Figure 1. Comparison of structural diversity of ER232 and ER1092 in a chemistry space defined by three
principal components of over 270 2D structural descriptors. Prediction Conﬁdence
Past results have shown that DF predic-
tions are of high confidence for active
chemicals with a large probability value
(approaching 1) and for inactive chemicals
with low probability value (approaching
zero), whereas the low confidence predic-
tions are mostly found for chemicals with
probability approaching 0.5 (Tong et al.
2003b). Based on this observation, the fol-
lowing equation was used to calculate the
conﬁdence level of a prediction:
conﬁdence level for chemical i = |Pi – 0.5|/0.5,
[1]
where Pi is the probability value for chemi-
cal i. In this equation, the conﬁdence asso-
ciated with active and inactive prediction is
scaled in parallel to the range between zero
and 1. If we assume that a high conﬁdence
prediction is defined as confidence
level > 0.4, both probability ranges of
0.0–0.3 and 0.7–1.0 will be considered the
high conﬁdence (HC) region, and 0.3–0.7
is the low conﬁdence (LC) region. In other
words, a high prediction certainty is
expected when a chemical with predicted
probability in the range 0.0–0.3 is classiﬁed
as inactive, or when a chemical with proba-
bility in the range 0.7–1.0 is predicted as
active. In contrast, prediction conﬁdence is
lower for chemicals with probabilities in
the range 0.3–0.7. 
Domain Extrapolation 
Suppose there is a forest that contains n
trees (i =1,…n). For the ith tree, the classiﬁ-
cation of an unknown chemical is deter-
mined by only one terminal node that is
descendent from the root node through a
set of “IF-THEN” rules based on k descrip-
tors xij (j=1,…k) (Figure 2). Let xij(max)
and xij(min) denote the maximum and
minimum values for xij across the entire
data set and yij denote the descriptor values
of the unknown chemicals corresponding
to xij. If yij is either > xij(max) or <xij(min),
then it is outside the range of the training
domain defined by xij in the “IF-THEN”
rule in the path from the root to the termi-
nal node in the ith tree. Thus, the distance
beyond the training domain for the
unknown chemical in the tree i can be
calculated by dij = |yij – xij(max)| if yij >
xij(max), dij = |yij – xij(min)| if yij < xij(min),
or dij = 0 if yij> xij(min) or yij < xij(max)
(within the training domain). For the for-
est, the total percentage of extrapolation
outside the training domain is:
[2]
The prediction accuracy within domain d
is calculated by dividing correct predictions
by total number of chemicals in this
extrapolated domain. 
Cross-Validation for Assessing
Prediction Conﬁdence and Domain
Extrapolation
We used 10-fold cross-validation to assess a
forest’s prediction accuracy for unknown
chemicals in different domains of predic-
tion confidence and extrapolation. In this
procedure the data set is randomly divided
into 10 equal portions, and each portion is
excluded once and predicted by the forest
produced using the remaining nine portions
to train the model. Because the 10-fold
cross-validation results vary for each run
due to random partitioning of the data set,
we repeated the process 2,000 times. The
average result of the multiple cross-
validation runs provides an unbiased assess-
ment of a forest for predicting unknown
chemicals with respect to prediction conﬁ-
dence and extrapolation sensitivity. 
Results
Table 1 summarizes the fitting results of
the forests for both the ER232 and
ER1092 data sets. The forests had concor-
dances around 95% with high specificity
and sensitivity.
Since a statistically sound fitted model
provides limited indication of its capability
for predicting chemicals that are not
included in training, we applied 2,000 runs
of 10-fold cross-validation to assess the pre-
diction conﬁdence and extrapolation sensi-
tivity of the model for predicting unknown
chemicals. 
Figure 3 plots forest prediction accuracy
versus prediction confidence for ER232
(Figure 3A) and ER1092 (Figure 3B),
respectively. For comparison, the results of
the ﬁrst tree in each forest are also plotted
in Figure 3. It is readily apparent that the
forests have substantially higher prediction
accuracy than the tree across the entire
range of confidence levels. Importantly,
there is a strong trend of higher accuracy
with increasing confidence level. We arbi-
trarily deﬁned two conﬁdence regions, HC
and LC corresponding to confidence
levels > 0.4 and < 0.4, respectively. Table 2
compares the HC, LC, and overall predic-
tion accuracy. The HC prediction accuracy
is approximately 86%, about 22% higher
than the prediction accuracy for the LC
regions (∼ 64%). There is about 5–7%
higher prediction accuracy for the HC
regions than for the overall prediction accu-
racy (Table 2). The HC predictions
account for approximately 80% of chemi-
cals for ER232 and approximately 70% for
ER1092.
On the basis of the same cross-valida-
tion results, we also assessed the prediction
accuracy for the chemicals as a function of
extrapolation outside the training domain.
Figure 4 compares for both ER232 and
ER1092 the overall prediction accuracy for
chemicals within the domain defined by
the training set chemicals with accuracy
for chemicals falling several degrees of
extrapolation outside the training domain,
as defined by Equation 2. Generally, the
farther away the chemicals were from the
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Figure 2. Schematic illustration for defining the
training domain of a tree. For an unknown chemi-
cal predicted by the tree, its classification is
determined by the terminal node (dark circle) to
which it belongs. There are three descriptors
used in the path (bold line) from the root to the
terminal node and the range of these three
descriptors across all chemicals in the training
set determines the training domain.
Table 1. Statistics of the forest models based on ER232 and ER1092. 
ER232 ER1092
Number of chemicals 232 1092
Number (%) of misclassiﬁcations 5 (2.16%) 50 (4.58%)
Number of trees combined 6 4
Number of descriptors used 79 138
Accuracy 96.6% 95.4%
Speciﬁcity 96.0% 91.0%
Sensitivity 96.9% 97.6%training domain, the more loss in predic-
tion accuracy was observed. For ER232
the prediction accuracy was reduced by
some 10% for chemicals with a 10%
extrapolation. In contrast for ER1092, a
major decrease in accuracy only occurred
beyond a 30% extrapolation. 
Table 3 further breaks down the over-
all prediction accuracy shown in Figure 4
into the accuracies for the HC and LC
regions and also gives the distribution of
predictions within the extrapolated
domains. For the HC prediction region
the trend of decreasing prediction accuracy
with increasing extrapolation is consistent
with Figure 4 for both ER232 and
ER1092. In the HC region for both data
sets, prediction accuracy is comparable
when extrapolation does not exceed 10%.
Prediction accuracy declines more notably
for chemicals with > 10% extrapolation for
ER232 (some with > 16%), and for chemi-
cals with > 30% extrapolation for ER1092.
In contrast the LC region prediction accu-
racy is consistently lower, as expected, and
exhibits no discernable trend with extent
of extrapolation.
Discussion
We used the novel QSAR method DF to
develop two classification models to pre-
dict ER binding. Such models could be
important in prioritizing chemicals for
testing based on likelihood of activity. We
furthermore objectively and quantitatively
assessed the applicability domains of the
models by computing prediction confi-
dence and domain extrapolation for pre-
dicting unknown chemicals with an
extensive cross-validation. We found that
accuracy in classifying unknown chemicals
is dependent on both prediction confi-
dence and domain extrapolation, with the
dependence most pronounced for predic-
tion confidence. The prediction accuracy
is notably higher for the chemicals in the
HC domain than for those in the LC
domain. In the HC domain, the forest
model based on the large data set ER1092
is much better able to extrapolate outside
the structural domain deﬁned by the train-
ing data than is the forest model based on
the small data set ER232 and specifically
by some 30% compared with 10%. We
propose that the ER1092 model is most
suitable for aiding in prioritizing chemicals
for testing as possible EDCs.
The consistently lower prediction accu-
racy in the LC domain compared to that of
the HC domain seems minimally affected
by the extent of extrapolation. For many
repeated runs of cross-validation with ran-
dom partitioning, chemicals in the HC
domain average 70–80% of the total for
both data sets. It should be noted that the
distribution of the chemicals between the
high and low conﬁdence regions could vary
when applying the model to a test set.
Actual distribution depends largely on how
well the training set represents the test set
chemicals. In the cross-validation, however,
the proportion of chemicals in the HC
domain is sensitive to the structural diversity
and quality of the training set. 
The ability to quantify confidence
greatly enhances the utility of any classiﬁca-
tion or QSAR method. The ability to accu-
rately gauge conﬁdence of predictions may
also determine how best to apply the
model. For example, considering the forest
models presented here for use in screening
and testing for potential EDCs, the HC
and LC domain predictions could be used
in separate ways. Chemicals in the HC
Toxicogenomics | Tong et al.
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Figure 3. Prediction accuracy versus confidence level. Data were calculated from 2,000 runs of 10-fold
cross-validation for (A) ER232 and (B) ER1092.
Table 2. The HC and LC predictions from 2,000 runs of 10-fold cross-validation for ER232 and ER1092. 
Conﬁdence ER232 ER1092
regions Accuracy (%) Percentage of chemicals  Accuracy (%) Percentage of chemicals
HC 86.6 79.2 86.3 69.9
LC 63.8 20.8 64.7 30.1
All 81.9 100 79.7 100
Abbreviations: HC , high conﬁdence; LC, low conﬁdence.domain are candidates for applying more
rigorous quantitative models (Shi et al.
2001) to calculate binding affinities that
are, in turn, used to rank-order chemicals
for experimental evaluation. However, for
chemicals in the LC domain, more thor-
ough evaluation based on other types of
models (Hong et al. 2002; Shi et al. 2002;
Tong et al. 2003a) and/or assays should
be required.
Validation is an important step in devel-
oping a useful QSAR model. There are two
common validation methods— cross-vali-
dation and external validation (Tong et al.
2003c). For most classification methods,
descriptor selection is normally executed
prior to model training. Without preselec-
tion of the descriptor variables, the compu-
tational expense of cross-validation could be
prohibitive. However, preselection of
descriptors also constitutes a bias, suggest-
ing that cross-validation may overestimate a
model’s true predictive accuracy for
unknown chemicals. For such cases prese-
lecting an external test set not used in train-
ing becomes critical to estimating predictive
accuracy. But, setting aside an external test
set detrimentally reduces the size of the
available training set, resulting in the loss of
data that would likely improve the model.
Ideally, the external test set would be ratio-
nally selected to represent the chemicals to
which the model would be applied. In real-
ity, however, because of the difficulty of
such a task, we are unaware of any model
development and test set selection in the
literature that incorporates a systematic
selection of a representative test set.
Bias in descriptor selection is not a factor
in DF, where in each step of the cross-vali-
dation a new set of descriptors is selected
that forms the best forest to represent each
random spilt between training and testing
data. The full integration of variable selec-
tion with forest construction means that the
cross-validation accuracy is more likely to
represent the true predictivity. Of course, a
prediction test on external data is always
desirable because it is a real-world applica-
tion of the model, but very rarely is suffi-
cient data available to warrant complete
exclusion of some data from the training
data. In a sense, cross-validation closely
resembles the conduct of multiple tests on
external data. Thus, we choose a rigorous
and extensive cross-validation method to
validate the models’ predictivities in this
study, which is able to assess many possible
partitions of the training and test sets and
then can provide an unbiased and objective
means for assessing a model’s quality.
A large number of QSAR models for
ER binding are reported in the literature
(Bradbury et al. 1996; Sadler et al. 1998;
Waller et al. 1996; Wiese et al. 1997;
Zheng and Tropsha 2000), including our
own (Tong et al. 1997a, 1997b, 1998;
Xing et al. 1999). Although these models
yield good statistical results, none explicitly
address and assess the confidence in pre-
dicting unknown chemicals. We demon-
strated in this study that there could be
more than a 22% difference in prediction
accuracy for the chemicals with high conﬁ-
dence compared with those with low conﬁ-
dence. Thus, for practical applications,
having prediction conﬁdence together with
the actual predictions greatly extends the
usefulness of QSAR and classiﬁcation mod-
els. In regulatory application, the justiﬁca-
tion for using such models may very well
depend on having measures of confidence
in the predictions.
Four types of uncertainty are generally
recognized as affecting the prediction conﬁ-
dence of a QSAR model (Tong et al.
2003c), and all generally are dependent on
either the nature of the data set or the
choice of the statistical algorithm. First, pre-
dictions from any model are intrinsically no
better than the experimental data employed
to develop the model. Any limitations of
the assay used to generate the training data
equally extends to the model’s predictions.
Second, commonly employed statistical
methods vary in their abilities to appropri-
ately capture the functional relationship of
structural descriptors and activity. Third,
for classification models specifically, class
assignment is sensitive to a defined cutoff
value to distinguish active from inactive. As
the cutoff value is lowered, it is likely that
the error will increase, even for a well-
designed and well-executed assay. The
increased experimental error in close prox-
imity to the cutoff value will be transferred
to the classification model, which in turn
will increase false prediction rate for chemi-
cals with activity in this region. Fourth, a
chemical can be represented by different
types of descriptors. We often find that,
even for a simple mechanism such as ER-
binding, some descriptors may well repre-
sent binding dependencies for one
structural class, whereas other features will
better represent binding dependencies for a
different structural class. In such cases,
regardless of how rigorously the validation
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Figure 4. Prediction accuracy in different domains of extrapolation for ER232 and ER1092 from 2,000 runs
of 10-fold cross-validation.
Table 3. Prediction accuracy in different regions of conﬁdence and extrapolation derived from 2,000 runs
of 10-fold cross-validation for ER232 and ER1092.
HC region LC region
Data set Extrapolation [(d) %] Accuracy (%) No. of predictions Accuracy (%) No. of predictions
ER232 0 87.8 349,595 64.7 83,393
0–10 79.7 10,442 55.8 6,216
10–20 61.1 1,325 50.5 2,651
20–30 65.3 853 63.9 1,086
> 30 39.7 5,614 65.9 2,825
ER1092 0 86.4 1,511,180 64.4 645,177
0–10 89.4 6,896 61.5 5,135
10–20 88.5 3,914 68.1 3,453
20–30 96.8 1,209 75.3 959
> 30 48.9 3,560 54.1 2,517procedure is employed, the model may give
incorrect predictions for some chemicals, as
the entire chemistry space of active chemi-
cals is unknown. These four types of uncer-
tainty determine the applicability domain
of a QSAR model, and adequate assessment
of this domain that bounds and guides the
model’s usage, especially in regulatory
application, is paramount. The assessment
procedure proposed in this study should be
equally applicable to other QSAR methods.
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